Mainz Short Term Debt from 2010 to 2025

MYNZ Stock  USD 4.20  0.42  9.09%   
Mainz Biomed Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt is likely to outpace its year average in 2025. During the period from 2010 to 2025, Mainz Biomed Short Term Debt regression line of annual values had r-squared of  0.51 and arithmetic mean of  1,331,835. View All Fundamentals
 
Short Term Debt  
First Reported
2019-03-31
Previous Quarter
5.2 M
Current Value
6.2 M
Quarterly Volatility
2.5 M
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.2 M or Interest Expense of 977.6 K, as well as many indicators such as Price To Sales Ratio of 919, Dividend Yield of 0.0 or PTB Ratio of 219. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Mainz Biomed BV over the last few years. It is Mainz Biomed's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

Mainz Short Term Debt Regression Statistics

Arithmetic Mean1,331,835
Geometric Mean425,239
Coefficient Of Variation170.22
Mean Deviation1,693,383
Median207,261
Standard Deviation2,267,016
Sample Variance5.1T
Range6.2M
R-Value0.72
Mean Square Error2.7T
R-Squared0.51
Significance0
Slope341,261
Total Sum of Squares77.1T

Mainz Short Term Debt History

20256.3 M
2024M
20235.2 M
20221.3 M
2021248.5 K
2020119.7 K

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term DebtM6.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.